Lori Muir

Lori Muir has extensive work experience in the pharmaceutical industry. Lori is currently serving as the Director of Clinical Operations at Spero Therapeutics since July 2020. Prior to this role, they held the position of Associate Director of Clinical Operations at the same company from January 2019 to July 2020. Before joining Spero Therapeutics, Lori worked at Arsanis as a Clinical Trial Manager from May 2016 to January 2019. Lori also worked as a Senior Clinical Consultant at McCormick LifeScience Consultants, LLC from July 2015 to January 2019. Earlier in their career, they held the position of Director of Clinical/Regulatory Affairs at ProMedDx, LLC from February 2002 to June 2015. Lori Muir started their professional journey as a Clinical Research Associate at Boston Medical Center (BMC) from August 1999 to July 2001. Lori also worked as an Associate Process Engineer at Bayer Diagnostics from March 1996 to April 1999. Lori began their career as a Process Development Assistant II at ImmuLogic Pharmaceuticals in 1993.

Lori Muir attended Syracuse University from 1989 to 1993, where they obtained a Bachelor of Science (B.S.) degree in Chemical Engineering. Additionally, they have obtained a certification in CCRA from ACRP, although the exact month and year of acquisition are unknown.